A novel HSF1 activator ameliorates non-alcoholic steatohepatitis by stimulating mitochondrial adaptive oxidation.
Rao Y, Li C, Hu YT, Xu YH, Song BB, Guo SY, Jiang Z, Zhao DD, Chen SB, Tan JH, Huang SL, Li QJ, Wang XJ, Zhang YJ, Ye JM, Huang ZS.
Rao Y, et al. Among authors: huang sl, huang zs.
Br J Pharmacol. 2022 Apr;179(7):1411-1432. doi: 10.1111/bph.15727. Epub 2022 Feb 9.
Br J Pharmacol. 2022.
PMID: 34783017
Free article.